Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine and intraoperative burst suppression in elderly frail lumbar fusion patients
ChiCTR2400091042Phase 4Completed
- Sponsor
- Second People's Hospital of Anhui Province
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in post-operative cognitive decline (POCD), Fragility and None (2 arms), sponsored by Second People's Hospital of Anhui Province. Primary endpoints: Incidence of intraoperative burst suppression, Frequency of intraoperative burst suppression and 1 more. Started Oct 2024; status: completed.
02
Drugs
esketamine
03
Conditions
post-operative cognitive decline (POCD)Fragility
Beyond the preview
Go deeper on ChiCTR2400091042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091042.